ZYBT — Zhengye Biotechnology Holding Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Zhengye Biotechnology Holding, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	6.28	9.75	16.3	20
Net Total Accounts Receivable
Net Total Receivables	102	134	99.4	88.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	165	214	189	178
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	246	275	263	255
Net Intangible Assets
Other Long Term Assets
Total Assets	445	520	500	493
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	126	152	150	136
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	178	223	227	209
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	267	296	273	284
Total Liabilities & Shareholders' Equity	445	520	500	493
Total Common Shares Outstanding